|
Dr. Dileep R. Yavagal, MD, MBBS, FSVIN, FAAN, FAHA
Professor of Clinical Neurology and Neurosurgery Director, Interventional Neurology Co-director Endovascular Neurosurgery Director, Neurological Stem Cell Platform, Interdisciplinary Stem Cell Institute Jackson Memorial & University of Miami Hospitals University of Miami Miller School Of Medicine Administrative Office: (305) 243-1745 [email protected] |
Dr. Yavagal’s research laboratory is engaged in research of Intra-arterial (IA) delivery of mesenchymal stem cells (MSCs) for acute ischemic stroke. His research laboratory uses multiple animal models with the goal of translating this treatment to stroke patients.
Intra-arterial delivery of stem cells for stroke
Dr. Dileep R. Yavagal, MD is Director of Interventional Neurology and Co-Director of Neuroendovascular Surgery and Clinical Professor of Neurology and Neurosurgery at the University of Miami & Jackson Memorial Hospitals. He is also the Director of NeuroStem Cell Division at the Interdisciplinary Stem Cell Institute. Dr. Yavagal is an international thought leader in endovascular therapy for ischemic and hemorrhagic stroke. Dr. Yavagal is a leader in both pre-clinical and clinical stroke as well as other neuroendovascular research. The translational approach of his work has allowed him to run a successful large and small animal research lab as well as initiate and collaborate with stake holders for cutting edge stroke clinical trials.
He was on the on the steering committee of the SWIFT-Prime and MR RESCUE, both landmark randomized clinical trials of endovascular stroke therapy. He co-authored the landmark 2015 AHA Endovascular Stroke Therapy Guidelines as well as the recent groundbreaking DAWN stroke trial in the New England Journal of Medicine. He is the founder and Past-President of the Society for Vascular and Interventional Neurology (SVIN). Dr. Yavagal has received several state, federal and private organization sponsored research grants to study endovascular stem cell therapies for ischemic stroke using small and large animal models of stroke in his research laboratory. He was the national Co-PI of the first US multicenter clinical trial of Intra-arterial delivery of autologous bone marrow stem cells for ischemic stroke: RECOVER Stroke. He is considered a pioneering researcher the field of intra-arterial delivery of stem cells in stroke therapy.
He was on the on the steering committee of the SWIFT-Prime and MR RESCUE, both landmark randomized clinical trials of endovascular stroke therapy. He co-authored the landmark 2015 AHA Endovascular Stroke Therapy Guidelines as well as the recent groundbreaking DAWN stroke trial in the New England Journal of Medicine. He is the founder and Past-President of the Society for Vascular and Interventional Neurology (SVIN). Dr. Yavagal has received several state, federal and private organization sponsored research grants to study endovascular stem cell therapies for ischemic stroke using small and large animal models of stroke in his research laboratory. He was the national Co-PI of the first US multicenter clinical trial of Intra-arterial delivery of autologous bone marrow stem cells for ischemic stroke: RECOVER Stroke. He is considered a pioneering researcher the field of intra-arterial delivery of stem cells in stroke therapy.